Global Opioid Use Disorder Market, By Drug (Buprenorphine, Methadone, Naltrexone), Application (Moderate Pain Treatment, Severe Pain Treatment), Mode of Administration (Injectables, Oral, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
The opioid use disorder market is expected to witness market growth at a rate of 8.10% in the forecast period of 2021 to 2028. Data Bridge Market Research report on the opioid use disorder market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increase in the prevalence of chronic diseases globally is escalating the growth of the opioid use disorder market.
Opioid use disorder refers to a condition in which patients are addicted/dependent on the consumption of opioids and generally related to environmental and genetic factors resulting in it arising in patients. The disorder is segregated into two categories, including opioids available as non-medicinal and patients reliant on medicinal opioid drugs.
The increase in the number of patients suffering from chronic pain among the population across the globe acts as one of the major factors driving the growth of the opioid use disorder market. The rise in the incidences of severe and chronic diseases among people such as cancer, cardiovascular disorder, and pain caused by injuries and others, and the high prevalence of opioid use disorder due to the consumption of painkillers containing opioids accelerate the market growth. The rise in the research and development activities and wide product pipeline further influence the market.
In addition, an increase in healthcare expenditure, surge in research funds and rise in research and development activities positively affect the opioid use disorder market. Furthermore, government initiatives extend profitable opportunities to the market players in the forecast period of 2021 to 2028.
On the other hand, limited product availability is expected to obstruct market growth. Lack of awareness is projected to challenge the opioid use disorder market in the forecast period of 2021-2028.
This opioid use disorder market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info opioid use disorder market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Opioid Use Disorder Market Scope and Market Size
The opioid use disorder market is segmented on the basis of drug, application, mode of administration, distribution channel and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of drug, the opioid use disorder market is segmented into buprenorphine, methadone and naltrexone.
- On the basis of application, the opioid use disorder market is segmented into moderate pain treatment and severe pain treatment.
- On the basis of mode of administration, the opioid use disorder market is segmented into injectables, oral and others.
- On the basis of distribution channel, the opioid use disorder market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
- On the basis of end user, the opioid use disorder market is segmented into hospitals, homecare, specialty clinics and others.
Global Opioid Use Disorder Market Country Level Analysis
The opioid use disorder market is analyzed and market size information is provided by country, drug, application, mode of administration, distribution channel and end user as referenced above.
The countries covered in the global opioid use disorder market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the opioid use disorder market due to the initiatives by the government and the presence of prominent players within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 because of the rise in awareness in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The opioid use disorder market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Opioid Use Disorder Market Share Analysis
The opioid use disorder market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related opioid use disorder market.
The major players covered in the opioid use disorder market report are Indivior PLC, Teva Pharmaceutical Industries Ltd., Omeros Corporation, Camurus, Hikma Pharmaceuticals PLC, Titan Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Alkermes, Novartis AG, Pear Therapeutics, Inc., Amygdala Neurosciences, Inc., Orexo AB (publ.), Braeburn Inc., iX Biopharma Ltd., Relmada Therapeutics, Inc. and Mundipharma International, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.